AIFinancial Times26 minutes ago
Insilico's Rentosertib Shows Age Reversal Potential
1 min read
Insilico's AI-driven IPF candidate Rentosertib shows potential for biological age reversal, according to six proteomic aging clocks. The company announcement, covered in Nature Biotechnology, highlights the drug's effect on aging biomarkers. Rentosertib targets idiopathic pulmonary fibrosis while demonstrating anti-aging properties.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
